Cryosite Limited (ASX:CTE)
Australia · Delayed Price · Currency is AUD 1.200
0.00 (0.00%)
Feb 24, 2026, 9:59 AM AEST
Cryosite Market Cap
Cryosite has a market cap or net worth of 58.57 million as of February 25, 2026. Its market cap has increased by 83.21% in one year.
Market Cap
58.57M
Enterprise Value
55.78M
Revenue
14.12M
Ranking
n/a
PE Ratio
31.75
Stock Price
1.20
Market Cap Chart
Since May 9, 2002, Cryosite's market cap has increased from 18.00 to 58.57M, an increase of 325,396,988.89%. That is a compound annual growth rate of 87.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 58.57M | 20.00% |
| Dec 29, 2025 | 48.81M | 17.65% |
| Dec 27, 2024 | 41.49M | 40.50% |
| Dec 29, 2023 | 29.53M | -17.12% |
| Dec 30, 2022 | 35.63M | 56.99% |
| Dec 31, 2021 | 22.70M | 22.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 894.51M |
| Healius | 501.03M |
| Australian Clinical Labs | 430.58M |
| Monash IVF Group | 282.49M |
| Rhythm Biosciences | 67.12M |
| Microba Life Sciences | 51.15M |
| INOVIQ | 47.16M |
| BCAL Diagnostics | 44.17M |